UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
New diabetes drug Steglatro fails to prove cardiovascular benefit
Steglatro (ingredient: ertugliflozin), the latecomer sodium-glucose co-tran...
by Kim Yun-mi
|
2020-06-19 14:55
라인
Yuyu to export SD Biosensor's Covid-19 test kit
Yuyu Pharmaceutical and SD Biosensor said they would cooperate in exporting...
by Lee Han-soo
|
2020-06-19 14:48
라인
Covid-19 fight drags on amid risks of 2nd viral wave
Korea's combat against the coronavirus pandemic is turning into a long-...
by Lee Han-soo
|
2020-06-19 12:42
라인
‘Covid-19 may be last straw that broke inter-Korean camel’s back’
Amid rampant speculations about what drove North Korea to sever ties with t...
by Shim Hyun-tai
|
2020-06-18 18:22
라인
GC got Japanese patent for NK cell-culture tech
GC LabCell said Thursday that it has acquired a patent for culturing method...
by Shim Hyun-tai
|
2020-06-18 17:53
라인
HK inno.N nabs FDA nod for trial of gastric acid blocker
HK inno.N, formerly known as CJ Healthcare, said that the U.S. Food and Dru...
by Lee Han-soo
|
2020-06-18 17:39
라인
AZ’s Imfinzi wins extra indication for small-cell lung cancer
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) has obtained l...
by Kim Yun-mi
|
2020-06-18 15:55
라인
5 key factors in successful secondary packaging and device assembly strategy
In his book The 7 Habits of Highly Effective People, Dr. Steven R. Covey of...
by Lee Han-soo
|
2020-06-18 15:52
라인
[Analysis] Revocation of Medytox license tolls death knell for once-promising biotech firm
Shares of Medytox nosedived Thursday after the Ministry of Food and Drug Sa...
by Lee Han-soo
|
2020-06-18 15:52
라인
Lilly beats Pfizer in treating early breast cancer
Pfizer was the first to release a drug for the treatment of hormone recepto...
by Kim Yun-mi
|
2020-06-18 14:44
라인
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
Roche Korea’s Tecentriq, the first immunotherapy to win indication for trip...
by Kim Yun-mi
|
2020-06-18 14:43
라인
New virus cases near 60 as cluster infections go south
Korea’s new Covid-19 cases rose to the highest level in three weeks on Thur...
by Shim Hyun-tai
|
2020-06-18 14:24
라인
Doctors group allows members to gain online training credit
The Korean Medical Association (KMA) decided on Wednesday to recognize doct...
by Shim Hyun-tai
|
2020-06-17 17:57
라인
Hospitals, clinics divided over telemedicine in post-Covid-19 era
The government is actively pushing to introduce telemedicine in the wake of...
by Kim Eun-young
|
2020-06-17 17:53
라인
GC MS to export Covid-19 test kits worth $30 million
GC Medical Science (GC MS) said Wednesday that it signed $30 million contra...
by Shim Hyun-tai
|
2020-06-17 17:48
라인
Korea’s Covid-19 treatment costs far lower than US’
The costs for treating Covid-19 are considerably cheaper in Korea compared ...
by Lee Han-soo
|
2020-06-17 17:04
라인
IOF aims to reduce osteoporosis-related fractures by 25% by 2025
The International Osteoporosis Foundation, a non-governmental organization ...
by Kim Yun-mi
|
2020-06-17 14:28
라인
JW Pharma to recreate its anticancer therapy as Covid-19 drug
JW Pharmaceutical said Wednesday that it would reposition CWP291, its antic...
by Shim Hyun-tai
|
2020-06-17 14:26
라인
Cluster infections in Daejeon push up local virus cases
New virus cases bounce backed above 40 on Tuesday, as cluster infections sp...
by Lee Han-soo
|
2020-06-17 12:37
라인
Regulator to discuss re-evaluation of choline alfoscerate
The Ministry of Food and Drug Safety said it would discuss whether to re-as...
by Kim Yun-mi
|
2020-06-17 12:36
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top